+
Epigral Posts Q1FY26 Revenue of Rs 6.15 Bn; PAT Surges to Rs 1.60 Bn
ECONOMY & POLICY

Epigral Posts Q1FY26 Revenue of Rs 6.15 Bn; PAT Surges to Rs 1.60 Bn

Epigral, India’s integrated chemical major, reported revenue of Rs 6.15 billion for the quarter ended June 30, 2025, compared to Rs 6.54 billion in Q1FY25—a 6 per cent year-on-year decline, driven by softer volumes and lower realisations. Despite this, the company maintained a stable EBITDA margin of 27 per cent, supported by efficiency gains and an improved product mix. EBITDA stood at Rs 1.63 billion, a 7 per cent dip over the previous year.

Profit after tax (PAT) for the quarter stood at Rs 1.60 billion, benefiting from a Rs 810 million decrease in deferred tax liability. Excluding this, PAT was Rs 790 million versus Rs 860 million in the same quarter last year. Plant utilisation stood at 73 per cent during the quarter. The company’s return on capital employed (ROCE) improved to 24 per cent, up from 21 per cent a year ago, driven by better earnings, while Net Debt/EBITDA fell to 0.6x from 1.6x, reflecting stronger operating performance and deleveraging.

Revenue contribution from the Derivatives and Specialty Chemicals segment reached 50 per cent, and management expects this to rise further in coming quarters. Ongoing capex for CPVC and Epichlorohydrin capacity expansion remains on track in terms of budget and timeline. Additionally, the company plans to announce new investments for a remaining land parcel within its integrated complex.

Commenting on the performance, Maulik Patel, Chairman and Managing Director, said, “We expect H2FY26 to be stronger than H1FY26. Our focus on new chemistry aligned with import substitution will support high growth and strong ROCE. We continue to strengthen our integrated operations while pursuing scalable and profitable growth.”

Epigral, India’s integrated chemical major, reported revenue of Rs 6.15 billion for the quarter ended June 30, 2025, compared to Rs 6.54 billion in Q1FY25—a 6 per cent year-on-year decline, driven by softer volumes and lower realisations. Despite this, the company maintained a stable EBITDA margin of 27 per cent, supported by efficiency gains and an improved product mix. EBITDA stood at Rs 1.63 billion, a 7 per cent dip over the previous year.Profit after tax (PAT) for the quarter stood at Rs 1.60 billion, benefiting from a Rs 810 million decrease in deferred tax liability. Excluding this, PAT was Rs 790 million versus Rs 860 million in the same quarter last year. Plant utilisation stood at 73 per cent during the quarter. The company’s return on capital employed (ROCE) improved to 24 per cent, up from 21 per cent a year ago, driven by better earnings, while Net Debt/EBITDA fell to 0.6x from 1.6x, reflecting stronger operating performance and deleveraging.Revenue contribution from the Derivatives and Specialty Chemicals segment reached 50 per cent, and management expects this to rise further in coming quarters. Ongoing capex for CPVC and Epichlorohydrin capacity expansion remains on track in terms of budget and timeline. Additionally, the company plans to announce new investments for a remaining land parcel within its integrated complex.Commenting on the performance, Maulik Patel, Chairman and Managing Director, said, “We expect H2FY26 to be stronger than H1FY26. Our focus on new chemistry aligned with import substitution will support high growth and strong ROCE. We continue to strengthen our integrated operations while pursuing scalable and profitable growth.”

Related Stories

Gold Stories

Next Story
Infrastructure Transport

Mumbai-Ahmedabad Bullet Train’s Surat-Vapi Section Set for 2027

The first section of the Mumbai-Ahmedabad Bullet Train corridor, linking Surat and Vapi, is targeted to begin services in 2027. Construction is expected to be completed by December 2026, while Railway Minister Ashwini Vaishnaw has indicated that an inauguration could take place around the middle of 2027. The National High Speed Rail Corporation (NHSRCL) said the train being manufactured in India is expected to reach the tracks around April or May 2027. The train will undergo extensive testing before the section is opened for passenger services. The project began construction in 2021 and includ..

Next Story
Infrastructure Transport

Indian Railways Approves Four Projects Worth Rs. 7.36 bn Across Four States

Indian Railways has approved four projects with a combined value of Rs. 7.36 bn across Uttar Pradesh, Maharashtra, Andhra Pradesh and Gujarat. The programme covers train protection, signalling, electric traction supply and a road overbridge, with each project assigned to a different railway zone. In Uttar Pradesh, Rs. 2.52 bn has been approved to extend the Kavach 4.0 automatic train protection system across 607.7 km in the Lucknow Division of North Eastern Railway. The system monitors train movements and can apply the brakes if a driver fails to observe a signal or exceeds a safe speed. The w..

Next Story
Infrastructure Urban

Chandru Raheja Sells 1.49% Stake in Mindspace REIT for Rs. 5 bn

Billionaire Chandru Lachmandas Raheja has sold a 1.49 per cent holding in Mindspace Business Parks REIT for Rs. 5 bn through a bulk deal on the BSE. The transaction involved 9.9 mn units and was executed at an average price of Rs. 505 per unit, according to exchange data. Following the sale, units of Mindspace Business Parks REIT were trading 0.18 per cent lower at Rs. 504.05 on Tuesday. Exchange data did not identify the buyers involved in the transaction. Raheja is the chairman of real estate company K Raheja Corp. The sale involved 99,00,990 units, representing 1.49 per cent of the Mumbai-b..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code